Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 May 16;282(6276):1565–1570. doi: 10.1136/bmj.282.6276.1565

Timolol after myocardial infarction: an answer or a new set of questions?

J R Mitchell
PMCID: PMC1505587  PMID: 6113020

Full text

PDF
1565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen M. P., Bechsgaard P., Frederiksen J., Hansen D. A., Jürgensen H. J., Nielsen B., Pedersen F., Pedersen-Bjergaard O., Rasmussen S. L. Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results. Lancet. 1979 Oct 27;2(8148):865–868. doi: 10.1016/s0140-6736(79)92684-9. [DOI] [PubMed] [Google Scholar]
  2. Clausen J., Felsby M., Jorgensen F. S., Nielsen B. L., Roin J., Strange B. Absence of prophylactic effect of propranolol in myocardial infarction. Lancet. 1966 Oct 29;2(7470):920–924. doi: 10.1016/s0140-6736(66)90533-2. [DOI] [PubMed] [Google Scholar]
  3. Freiman J. A., Chalmers T. C., Smith H., Jr, Kuebler R. R. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med. 1978 Sep 28;299(13):690–694. doi: 10.1056/NEJM197809282991304. [DOI] [PubMed] [Google Scholar]
  4. Hampton J. R., Harrison M. J., Honour A. J., Mitchell J. R. Platelet behaviour and drugs used in cardiovascular disease. Cardiovasc Res. 1967 Apr;1(2):101–107. doi: 10.1093/cvr/1.2.101. [DOI] [PubMed] [Google Scholar]
  5. Hampton J. R., Harrison M. J., Honour A. J., Mitchell J. R., Prichard J. S. Assessment of antithrombotic agents: effects of dipyridamole analogues on platelet behaviour. Cardiovasc Res. 1972 Nov;6(6):696–701. doi: 10.1093/cvr/6.6.696. [DOI] [PubMed] [Google Scholar]
  6. Hampton J. R. Presentation and analysis of the results of clinical trials in cardiovascular disease. Br Med J (Clin Res Ed) 1981 Apr 25;282(6273):1371–1373. doi: 10.1136/bmj.282.6273.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Heptinstall S., Mulley G. P., Taylor P. M., Mitchell J. R. Platelet-release reaction in myocardial infarction. Br Med J. 1980 Jan 12;280(6207):80–81. doi: 10.1136/bmj.280.6207.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hill J. D., Hampton J. R., Mitchell J. R. A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet. 1978 Apr 22;1(8069):837–841. doi: 10.1016/s0140-6736(78)90190-3. [DOI] [PubMed] [Google Scholar]
  9. Mitchell J. R. Anticoagulants in coronary heart disease--retrospect and prospect. Lancet. 1981 Jan 31;1(8214):257–262. doi: 10.1016/s0140-6736(81)92095-x. [DOI] [PubMed] [Google Scholar]
  10. Mitchell J. R. Clinical events resulting from thrombus formation. Br Med Bull. 1978 May;34(2):103–106. doi: 10.1093/oxfordjournals.bmb.a071478. [DOI] [PubMed] [Google Scholar]
  11. Mitchell J. R. Secondary prevention of myocardial infarction--the present state of the ART. Br Med J. 1980 May 3;280(6223):1128–1130. doi: 10.1136/bmj.280.6223.1128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schaal S. F., Wallace A. G., Sealy W. C. Protective influence of cardiac denervation against arrhythmias of myocardial infarction. Cardiovasc Res. 1969 Jul;3(3):241–244. doi: 10.1093/cvr/3.3.241. [DOI] [PubMed] [Google Scholar]
  13. Snow P. J. Effect of propranolol in myocardial infarction. Lancet. 1965 Sep 18;2(7412):551–553. doi: 10.1016/s0140-6736(65)90863-9. [DOI] [PubMed] [Google Scholar]
  14. Temple R., Pledger G. W. The FDA's critique of the anturane reinfarction trial. N Engl J Med. 1980 Dec 18;303(25):1488–1492. doi: 10.1056/NEJM198012183032534. [DOI] [PubMed] [Google Scholar]
  15. Wilcox R. G., Roland J. M., Banks D. C., Hampton J. R., Mitchell J. R. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J. 1980 Mar 29;280(6218):885–888. doi: 10.1136/bmj.280.6218.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wilcox R. G., Roland J. M., Hampton J. R. Prognosis of patients with "chest pain ?cause". Br Med J (Clin Res Ed) 1981 Feb 7;282(6262):431–433. doi: 10.1136/bmj.282.6262.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wilcox R. G., Rowley J. M., Hampton J. R., Mitchell J. R., Roland J. M., Banks D. C. Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet. 1980 Oct 11;2(8198):765–769. doi: 10.1016/s0140-6736(80)90385-2. [DOI] [PubMed] [Google Scholar]
  18. Yusuf S., Ramsdale D., Peto R., Furse L., Bennett D., Bray C., Sleight P. Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial. Lancet. 1980 Aug 9;2(8189):273–276. doi: 10.1016/s0140-6736(80)90231-7. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES